| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| - | - | 4,700 | ₹0.6 0% | 1,0000% |
| - | - | 4,800 | ₹0.5 -79.59% | 1,000-20% |
| 3750% | ₹813.7 0% | 4,900 | ₹0.1 -33.33% | 3,7500% |
| 3750% | ₹877.45 0% | 4,950 | ₹0.3 0% | 3,375-3.57% |
| 5000% | ₹568 0% | 5,000 | ₹0.25 0% | 1,5000% |
| 7500% | ₹663.75 0% | 5,050 | ₹12.9 0% | 1,1250% |
| 5,1250% | ₹729 0% | 5,100 | ₹0.7 -39.13% | 10,375-6.74% |
| - | - | 5,150 | ₹0.4 -84.31% | 750-33.33% |
| 00% | ₹434.8 0% | 5,200 | ₹11.95 2,887.5% | 16,2505.69% |
| - | - | 5,250 | ₹4.7 -1.05% | 2,3750% |
| - | - | 5,300 | ₹2.5 163.15% | 3,500-6.66% |
| - | - | 5,350 | ₹9.7 0% | 7500% |
| 1,8750% | ₹323.45 0% | 5,400 | ₹2 48.14% | 20,875-6.17% |
| 1,6250% | ₹343.85 0% | 5,450 | ₹1.5 30.43% | 16,875-0.73% |
| 7,375-4.83% | ₹270 5.34% | 5,500 | ₹1.8 16.12% | 12,000-9.43% |
| 6,375-1.92% | ₹200 7.61% | 5,550 | ₹1.8 -47.82% | 9,500-22.44% |
| 16,875-6.25% | ₹126.1 -12.7% | 5,600 | ₹3.1 -64.57% | 11,500-14.81% |
| 6,2500% | ₹155.55 55.08% | 5,650 | ₹12.6 -38.98% | 3,125-28.57% |
| 11,125-8.24% | ₹48.55 -41.71% | 5,700 | ₹20.05 -47.78% | 15,625-1.57% |
| 2,750-56.86% | ₹26 -59.96% | 5,750 | ₹61.9 -6.77% | 3,125-50.98% |
| 9,000-45.86% | ₹17.25 -62.78% | 5,800 | ₹84 -5.08% | 7,625-22.78% |
| 15,875-14.18% | ₹13 -59.11% | 5,850 | ₹110 -16.03% | 4,625-33.92% |
| 17,250-24.59% | ₹9.05 -62.68% | 5,900 | ₹180.1 -7.09% | 3,875-8.82% |
| 9,125-17.04% | ₹4.6 -69.93% | 5,950 | - | - |
| 55,625-14.75% | ₹3.75 -66.81% | 6,000 | ₹282.5 0% | 8750% |
| 3,750-43.39% | ₹2.6 -30.66% | 6,050 | ₹338.8 0% | 1250% |
| 37,500-0.99% | ₹1.55 -69.6% | 6,100 | ₹260 0% | 1250% |
| 8,625245% | ₹2.2 -49.42% | 6,150 | - | - |
| 16,25032.65% | ₹1.75 -46.96% | 6,200 | - | - |
| 24,87519.87% | ₹1.1 -65.07% | 6,250 | - | - |
| 7,250-12.12% | ₹0.55 -75.55% | 6,300 | - | - |
| 6250% | ₹1.45 -14.7% | 6,350 | - | - |
| 10,000-17.52% | ₹1.1 -8.33% | 6,400 | ₹679.15 0% | 7500% |
| 40,1250% | ₹1 -23.07% | 6,500 | - | - |
This inspection, conducted from March 10 through March 13, 2025, was to evaluate compliance with the legal standards concerning bioequivalence studies.
The company saw its revenues increase by 1.5% YoY at ₹3,374 crore from ₹3,324 crore.
The serum contains liposomal azelaic acid, liposomal 4-butyl resorcinol, tranexamic acid, alpha arbutin, and niacinamide.
R&D expenses rose to ₹146.5 crore, making up 4.3% of total revenue, compared to ₹115.8 crore (3.4% of revenue) in the previous year.
This comes after competing private equity firms TPG Capital, Apax Partners, and KKR withdrew their original interest.
Alkem will conduct clinical trials of 'SON-080' in India, with Sonnet's support for global and local regulatory submissions.
According to sources, the floor price would be ₹5,616 per share, which is 3% lower than the current market price (CMP).
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
